Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,201 | 14,995 | 12,973 | 8,417 | 20,541 |
| Marketable Securities | 0 | 600 | 3,045 | 16,915 | 10,355 |
| Receivables | 373 | 403 | 309 | 602 | 127 |
| Inventories | 9,416 | 8,772 | 5,971 | 1,794 | 1,843 |
| TOTAL | $21,194 | $26,096 | $23,758 | $28,440 | $33,606 |
| Non-Current Assets | |||||
| PPE Net | 3,484 | 3,403 | 2,540 | 1,799 | 1,283 |
| Intangibles | 701 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 8,498 | 8,279 | 5,950 | 2,335 | 2,413 |
| TOTAL | $12,683 | $11,682 | $8,490 | $4,134 | $3,696 |
| Total Assets | $33,877 | $37,778 | $32,248 | $32,574 | $37,302 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 705 | N/A | N/A | 24 | N/A |
| Accounts payable and accrued liabilities | 6,740 | 6,959 | 4,928 | 4,725 | 5,044 |
| Other current liabilities | 263 | 263 | 306 | 306 | 266 |
| TOTAL | $8,408 | $8,364 | $5,808 | $5,708 | $6,023 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,548 | 2,742 | 130 | 107 | 113 |
| Deferred Revenues | N/A | N/A | 17 | 42 | 80 |
| Other Non-Current Liabilities | 11,693 | 13,261 | 14,189 | 18,433 | 16,933 |
| TOTAL | $13,467 | $15,798 | $14,217 | $18,540 | $17,046 |
| Total Liabilities | $21,875 | $24,162 | $20,025 | $24,248 | $23,069 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 271 | 267 | 216 | 216 | 216 |
| Common Shares | 51 | 50 | 49 | 49 | 49 |
| Retained earnings | -220,725 | -214,335 | -204,646 | -207,171 | -200,928 |
| Other shareholders' equity | 722 | 1,496 | 1,208 | 622 | 689 |
| TOTAL | $12,002 | $13,616 | $12,223 | $8,326 | $14,233 |
| Total Liabilities And Equity | $33,877 | $37,778 | $32,248 | $32,574 | $37,302 |